O’Melveny Worldwide

O’Melveny Represents Underwriters in Hong Kong IPO of Shanghai HeartCare Medical Technology Corporation Limited

August 20, 2021

FOR IMMEDIATE RELEASE

HONG KONG—AUGUST 20, 2021—O’Melveny recently represented Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the HK$1.13 billion (approximately US$145 million) initial public offering and listing of shares by Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) on the Main Board of the Hong Kong Stock Exchange.  Assuming full exercise of the over-allotment option, the offering size will be HK$1.30 billion (approximately US$167 million).

Founded in 2016, Shanghai HeartCare is an innovative neuro-interventional medical device company with an established leadership position in the neuro-intervention market in China by virtue of its broad portfolio of commercialized products and product candidates, which include neuro-interventional and cardiac medical devices.

The O’Melveny team was led by corporate partners Ke Geng and Ke Zhu, and included counsel Ye Sun and Wendy Kan, associates Katherine Wang, Edward Poon, and Hilda Leung, trainee solicitor Julianna Chan, legal consultant Ningzhi Chen, as well as legal consultant intern Elle Mei. Partner Luc Moritz, counsel James M. Harrigan, Billy Abbott, Qianyu Hu, and Xueyin Zhong, and associate Dawn Lim also provided valuable support.

About O’Melveny

It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com or learn more in our firm at-a-glance, year-end highlights, and on LinkedIn, Twitter, Facebook, Instagram, and YouTube.

Contact:

Christopher Rieck
O’Melveny & Myers LLP
+1 212 326 2218
crieck@omm.com

Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com